Riskpilot← Back to searchSign inGet full accessDynaMed AB
ABActiveOrg 5590989736Lerskärsvägen 35General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 1,2M
+8% vs 2023
EBITDA margin
16.6%
-39% vs 2023
Equity ratio
40.3%
Financial strength
Net profit 2024
SEK 159K
-39% vs 2023
| Revenue | SEK 1,2M | +8% |
| EBITDA | SEK 202K | -39% |
| Net profit | SEK 159K | -39% |
| Total assets | SEK 522K | -6% |
| Equity | SEK 210K | -33% |
| Employees | 0 | — |
Legal name
DynaMed AB
Org number
5590989736
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är sjukvård, förebygga-, diagnostisera-, utreda- och behandla sjukdomar och skador och därmed förenlig verksamhet. Idrottsmedicin samt idrottsläkare. Kurs och utbildning kring idrottsskador och även försäljning av produkter inom sjukvård och friskvård. Kosmetiska injektioner och därmed förenlig verksamhet.
Address
Lerskärsvägen 35
Email
sofia.gothe@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 744 | 763 | 421 | 1 121 | 1 216 |
| Staff expenses | — | — | −51 | −501 | −609 |
| EBITDA | 455 | 270 | 76 | 331 | 202 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 455 | 270 | 76 | 331 | 202 |
| Net financials | — | — | −0 | 2 | 1 |
| Profit before tax | 456 | 270 | 76 | 333 | 203 |
| Tax | −99 | −57 | −17 | −70 | −43 |
| Net profit | 357 | 213 | 59 | 263 | 159 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 636 | 650 | 296 | 554 | 522 |
| Equity | 434 | 397 | 128 | 316 | 210 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 202 | 253 | 168 | 239 | 312 |
| Total debt | 202 | 253 | 168 | 239 | 312 |
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
20202024
Equity ratio
40.3%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
75.8%
This company
18.4%
Market median
+312% vs market
20202024
Net profit margin
13.1%
This company
8.1%
Market median
+62% vs market
20202024
Asset turnover
2.33×
This company
1.12×
Market median
+108% vs market
20202024
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DynaMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Jonas Lund Bjerke | Deputy Board Member | 0 companies |
| Emmy Sofia Magdalena Göthe | Board of Directors | 0 companies |